EMA — authorised 27 July 2018
- Marketing authorisation holder: OTSUKA PHARM CO LTD
- Status: approved
🇪🇺 Rexulti in European Union
EMA authorised Rexulti on 27 July 2018
Marketing authorisation
Rexulti in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Rexulti approved in European Union?
Yes. EMA authorised it on 27 July 2018.
Who is the marketing authorisation holder for Rexulti in European Union?
OTSUKA PHARM CO LTD holds the EU marketing authorisation.